MedTrace Logo

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

NCT04950218 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-09-15

No results posted yet for this study

Summary

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.

Conditions

  • Psoriasis
  • Cardiovascular Diseases
  • Cardiovascular Risk Factor
  • Cardiovascular Pathology
  • Psoriasis Vulgaris
  • Psoriatic Nail
  • Psoriasis Face
  • Psoriasis Guttate
  • Psoriasis Gyrata
  • Psoriasis Diffusa
  • Psoriasis Palmaris
  • Psoriasis Annularis
  • Psoriasis Circinata
  • Psoriasis Plantaris
  • Psoriasis Universalis
  • Psoriasis Geographica
  • Left Ventricular Dysfunction
  • Myocardial Infarction
  • Myocardial Ischemia
  • Heart Failure
  • Stroke
  • Heart Diseases
  • Heart Failure, Systolic
  • Heart Failure, Diastolic

Sponsors & Collaborators

  • Herlev and Gentofte Hospital

    lead OTHER

Principal Investigators

  • Tor Biering-Sørensen, MD, PhD, MPH · Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen

  • Claus Zachariae, MD, DMSc · Department of Dermato-Allergology, Herlev and Gentofte University Hospital, University of Copenhagen

  • Lone Skov, MD, PhD, DMSc · Department of Dermato-Allergology, Herlev and Gentofte University Hospital, University of Copenhagen

  • Gunnar Gislason, MD, PhD · Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2034-10-01
Completion
2034-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04950218 on ClinicalTrials.gov